BRPI0612848A8 - manopartículas de isoflavona e usos das mesmas - Google Patents

manopartículas de isoflavona e usos das mesmas

Info

Publication number
BRPI0612848A8
BRPI0612848A8 BRPI0612848A BRPI0612848A BRPI0612848A8 BR PI0612848 A8 BRPI0612848 A8 BR PI0612848A8 BR PI0612848 A BRPI0612848 A BR PI0612848A BR PI0612848 A BRPI0612848 A BR PI0612848A BR PI0612848 A8 BRPI0612848 A8 BR PI0612848A8
Authority
BR
Brazil
Prior art keywords
isoflavone
compositions
mannoparticles
composition
nanoparticle
Prior art date
Application number
BRPI0612848A
Other languages
English (en)
Inventor
Chen Chyi-Cheng
Zedi Ernst
Gutzwiller Heinz
H Vollhardt Juergen
Emmanuel Maillan Philippe
Beumer Raphael
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of BRPI0612848A2 publication Critical patent/BRPI0612848A2/pt
Publication of BRPI0612848A8 publication Critical patent/BRPI0612848A8/pt
Publication of BRPI0612848B1 publication Critical patent/BRPI0612848B1/pt
Publication of BRPI0612848B8 publication Critical patent/BRPI0612848B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/20—Ingredients acting on or related to the structure
    • A23V2200/25—Nanoparticles, nanostructures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dermatology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

composição de nanoparticulas de isoflavona, processo para a produção da mesma e seu uso, composição farmaceutica, composição cosmética, e produto nutricional. a presente invenção refere-se às composições de nanopartículas de isoflavona que compreendem isoflavona na forma de nanopartículas e, de preferência, um veículo. as composições de nanopartículas de isoflavona são particularmente úteis para a preparação de composições cosméticas, composições farmacêuticas, gêneros alimentícios, alimentos e aditivos alimentícios. nas composições que compreendem as composições de nanopartículas de isoflavona, a recristalização da isoflavona em partículas maiores é retardada.
BRPI0612848A 2005-06-29 2006-01-31 composição de nanopartículas de isoflavona, processo para a produção da mesma e seu uso, composição farmacêutica, composição cosmética, e produto nutricional BRPI0612848B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05014096.1 2005-06-29
EP05014096 2005-06-29
PCT/EP2006/000827 WO2007000193A1 (en) 2005-06-29 2006-01-31 Isoflavone nanoparticles and use thereof

Publications (4)

Publication Number Publication Date
BRPI0612848A2 BRPI0612848A2 (pt) 2010-11-30
BRPI0612848A8 true BRPI0612848A8 (pt) 2017-12-26
BRPI0612848B1 BRPI0612848B1 (pt) 2020-03-31
BRPI0612848B8 BRPI0612848B8 (pt) 2021-05-25

Family

ID=36013328

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612848A BRPI0612848B8 (pt) 2005-06-29 2006-01-31 composição de nanopartículas de isoflavona, processo para a produção da mesma e seu uso, composição farmacêutica, composição cosmética, e produto nutricional

Country Status (9)

Country Link
US (1) US8951560B2 (pt)
EP (1) EP1904053B1 (pt)
JP (1) JP5134535B2 (pt)
KR (1) KR101242851B1 (pt)
CN (1) CN101212964A (pt)
AT (1) ATE520396T1 (pt)
BR (1) BRPI0612848B8 (pt)
ES (1) ES2369928T3 (pt)
WO (1) WO2007000193A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5129130B2 (ja) * 2005-06-29 2013-01-23 ディーエスエム アイピー アセッツ ビー．ブイ． イソフラボンのナノ粒子を含む局所組成物
EP2099420B8 (en) * 2006-11-17 2017-03-15 PharmaSol GmbH Nanocrystals for use in topical cosmetic formulations and method of production thereof
US9707185B2 (en) 2007-05-07 2017-07-18 Board Of Supervisors Of Louisana State University And Agricultural And Mechanical College Water-soluble nanoparticles containing water-insoluble compounds
JP2011503232A (ja) 2007-11-20 2011-01-27 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド 免疫応答の調節
FR2932488B1 (fr) * 2008-06-13 2012-10-26 Roquette Freres Compositions thermoplastiques ou elastomeriques a base d'amidon et procede de preparation de telles compositions.
IT1394148B1 (it) 2008-09-12 2012-05-25 Visottica Ind S P A Con Unico Socio Cerniera elastica a doppio scatto per occhiali
BRPI0923504A2 (pt) * 2008-12-11 2020-05-26 Axcentua Pharmaceuticals Ab Formas cristalinas de genisteína.
US20100215700A1 (en) * 2009-02-25 2010-08-26 Conopco, Inc., D/B/A Unilever Shear Gels and Compositions Comprising Shear Gels
WO2011049629A2 (en) * 2009-10-22 2011-04-28 Api Genesis, Llc Methods of making and using compositions comprising flavonoids
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
US8900635B2 (en) 2010-11-15 2014-12-02 Humanetics Corporation Nanoparticle isoflavone compositions and methods of making and using the same
BRPI1101820A2 (pt) * 2011-04-29 2013-06-18 Hebron Farmacêutica - Pesq. Des. E Inovação Tec. Ltda composiÇÕes farmacÊuticas e seus usos para tratamento e/ou prevenÇço de doenÇas decorrentes do hipoestrogenismo no trato genital inferior feminino
US9623003B1 (en) 2013-04-04 2017-04-18 Humanetics Corporation Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein
US9623004B2 (en) 2013-08-02 2017-04-18 Humanetics Corporation Administration of a therapeutic amount of genistein to mitigate erectile dysfunction resulting from radiation therapy for prostate cancer only throughout a defined administration period commencing shortly before and concluding after radiation therapy
US9084726B2 (en) 2013-11-26 2015-07-21 Humanetics Corporation Suspension compositions of physiologically active phenolic compounds and methods of making and using the same
WO2015087329A1 (en) 2013-12-12 2015-06-18 Technion Research & Development Foundation Limited Pectin based nanoparticles
FI126755B (en) * 2014-04-28 2017-05-15 Kemira Oyj A process for preparing a suspension from microfibrillated cellulose, microfibrillated cellulose and its use
FR3023474B1 (fr) * 2014-07-09 2016-07-22 Oreal Huile anhydre a base de particules a liberation d'agent benefique
CN114306275B (zh) * 2021-12-24 2023-05-26 齐鲁工业大学 一种豌豆肽负载大豆异黄酮复合纳米粒子及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU642066B2 (en) * 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5824702A (en) * 1996-06-07 1998-10-20 Mount Sinai School Of Medicine Of The City University Of New York Genistein as a preventive against ultraviolet induced skin photodamage and cancer
EP1051171A1 (en) 1998-01-28 2000-11-15 Dusan Miljkovic Isoflavanoid formulations for oral administration
DE19825856A1 (de) 1998-06-10 1999-12-16 Labtec Gmbh Topische Arzneimittelzubereitung
ES2209813T3 (es) * 1999-01-25 2004-07-01 Ecosynthetix Inc. Nanoparticulas de biopolimeros.
JP4006133B2 (ja) * 1999-05-17 2007-11-14 松谷化学工業株式会社 可溶性イソフラボン組成物及びその製造方法
FR2817478A1 (fr) * 2000-12-04 2002-06-07 Oreal Suspensions aqueuses de nanospheres de principes actifs lipophiles
US20040256749A1 (en) 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
FR2820320B1 (fr) * 2001-02-02 2003-04-04 Oreal Suspension de nanospheres de principe actif lipophile stabilisee par des polymeres hydrodispersibles
DE10114305A1 (de) * 2001-03-23 2002-09-26 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Isoflavonen und Verwendung von Isoflavonen zur Herstellung kosmetischer und dermatologischer Zubereitungen zur Reduktion des Sebumgehaltes der Haut
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
JP4013034B2 (ja) * 2001-10-24 2007-11-28 横浜油脂工業株式会社 可溶化性イソフラボン組成物、その製造法及びイソフラボン含有水性飲料の製造方法
US20030175345A1 (en) * 2001-12-06 2003-09-18 Hite Michael P. Isoflavone composition for oral delivery
WO2003068008A1 (en) * 2002-02-14 2003-08-21 Dsm Ip Assets B.V. Water-dispersible coenzyme q10 dry powders
JP5129130B2 (ja) * 2005-06-29 2013-01-23 ディーエスエム アイピー アセッツ ビー．ブイ． イソフラボンのナノ粒子を含む局所組成物

Also Published As

Publication number Publication date
BRPI0612848A2 (pt) 2010-11-30
WO2007000193A9 (en) 2007-12-13
BRPI0612848B8 (pt) 2021-05-25
EP1904053A1 (en) 2008-04-02
ES2369928T3 (es) 2011-12-09
US8951560B2 (en) 2015-02-10
JP5134535B2 (ja) 2013-01-30
ATE520396T1 (de) 2011-09-15
CN101212964A (zh) 2008-07-02
JP2008544963A (ja) 2008-12-11
US20090035336A1 (en) 2009-02-05
KR101242851B1 (ko) 2013-03-12
KR20080020643A (ko) 2008-03-05
EP1904053B1 (en) 2011-08-17
BRPI0612848B1 (pt) 2020-03-31
WO2007000193A1 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
BRPI0612848A8 (pt) manopartículas de isoflavona e usos das mesmas
BR112014010978A2 (pt) material rico em genipina e seu uso
BRPI0508879A (pt) transferência de ingredientes funcionais
BR112015027372A2 (pt) Método para preparar uma base de aveia líquida para uso na fabricação de alimentos para consumo humano, base de aveia líquida, base de aveia em pó, uso da base de aveia líquida, uso da base de aveia em pó, bebida de sabor de fruta, bebida de iogurte com alto nível de fibra, produto alimentício, e, composição em pó para uso na produção de base de aveia líquida
BRPI0804806A2 (pt) composição de lipìdio útil na formulação de produtos alimentìcios, produto alimentìcio e métodos para formar uma mistura de lipìdios estruturados e para deslocar mais conteúdo de energia do mesmo para processos termogênicos e menos conteúdo de energia do mesmo para armazenamento de gordura corporal
BR112012025943A2 (pt) compostos, composições e métodos para reduzir ou eliminar o sabor amargo.
NO20085374L (no) Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose
BR112013009056A2 (pt) extratos de café como ingredientes de alimentos, fármacos, cosméticos, suplementos dietéticos e produtos biológicos
RU2012114586A (ru) Композиция для стимулирования продуцирования ламинина-332
BR112015007074A2 (pt) gel para a preparação de um produto de alimentação
BR112013005912A2 (pt) métodos de tratar o aumento de próstata, de decrescer os níveis de triglicerídeos em sangue, de reduzir os níveis de glicose, de aumentar o peso pós-natal, de aumentar as taxas de sobrevivência pós-natal de prole, de aumentar a função imunológica, e de tratar distúrbio de déficit de atenção, composição de fórmula para bebê, composição nutricional, e, ingrediente alimentício
EA201001580A1 (ru) Жевательные кондитерские изделия
BR112012026714A2 (pt) pastilhas de eritritol e isomalte
BR112013013908A2 (pt) produtos alimentícios para crianças compreendendo grãos integrais hidrolisados
WO2012006041A3 (en) Hydroxypropyl substituted starches as source of soluble fiber
BR112012012656A2 (pt) composicoes adocantes e seu processo de fabricacao
BRPI0717713A8 (pt) "composições alimentícias instantâneas, processo para reduzir o nível de sódio em uma composição alimentícia e processo para preparar uma composição alimentícia pronta para comer"
CN101700121A (zh) 胶原蛋白软胶囊
MX351668B (es) Zeolitica activada y micronizada, proceso para su activacion y micronizacion y su utilizacion como acarreador en preparaciones farmaceuticas y suplementos alimenticios.
BRPI0910256A8 (pt) Usos de alternan como agente de texturização em ingredientes alimentícios, composições homogêneas, seus método de preparação e seus usos
GR1007520B (el) Ταυτοχρονη εκχυλιση και σχηματισμος συμπλοκων εγκλεισμου των δραστικων συστατικων της προπολης με υδροξυπροπυλο-β-κυκλοδεξτρινη
FR2981246B1 (fr) Produit alimentaire utile comme supplement nutritionnel ou repas complet
CN101697804A (zh) 玫瑰精油软胶囊
BR112014008454A2 (pt) processo para a fabricação de produtos alimentícios, produto de carne e lanche
BR112014027388A2 (pt) formulação de vitamina aquosa estéril

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/352 (2006.01), A23K 20/121 (2016.01), A23L

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 31/03/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/01/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25A Requested transfer of rights approved

Owner name: HUMANETICS CORPORATION (US)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2707 DE 22-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.